Clinical Trials Directory

Trials / Terminated

TerminatedNCT01490840

Effect of Physical ACtivity in Fingolimod Treated patiEnts (PACE) With Relapsing-remitting Multiple Sclerosis

A 6-month, Multicenter, Randomized, Controlled Parallel Group Study to Evaluate the Effect of Physical Training on Fatigue in Patients With Relapsing-remitting Multiple Sclerosis Treated With Fingolimod, Followed by a 6 Month Optional Extension Phase

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
178 (actual)
Sponsor
Novartis Pharmaceuticals · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study evaluated the effect of an individualized web-based physical training in fingolimod -treated patients.

Detailed description

In this study, it was planned to randomize 226 participants. However, only 178 participants were randomized during a timeframe of 2 years and 8 months. Therefore, the study was terminated due to slow enrollment and low participant compliance to the physical training schedule.

Conditions

Interventions

TypeNameDescription
OTHERPhysical exerciseStrength training exercises are performed against own body weight or with training aids like elastic rubber bands or gym balls. All exercises are home-based. To increase balance and core stability, a subset of exercises is performed on shaky ground and/or one-legged. Exercise intensity, duration and frequency are individually assigned by a sports therapist. For each muscle group, a set of exercises of increasing difficulty allows for individual and progressive training adaption. Therapists can choose from an exercise database of approximately 150 different strength exercises with different graduation.

Timeline

Start date
2011-11-01
Primary completion
2014-07-01
Completion
2014-07-01
First posted
2011-12-13
Last updated
2016-05-12
Results posted
2016-05-12

Locations

32 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT01490840. Inclusion in this directory is not an endorsement.